Citation Impact
Citing Papers
Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia.
2006
Consensus Statement on Chronic and Subacute High Altitude Diseases
2005
Haematological rather than skeletal muscle adaptations contribute to the increase in peak oxygen uptake induced by moderate endurance training
2015
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Hypoxia-inducible factors regulate human and rat cystathionine β-synthase gene expression
2013 StandoutNobel
Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation
2014
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
2009 StandoutNobel
Effects of cellular iron deficiency on the formation of vascular endothelial growth factor and angiogenesis.
2010
Changes in the intestine microbial, digestion and immunity of Litopenaeus vannamei in response to dietary resistant starch
2019 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation
2011 StandoutNobel
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
2016 Standout
Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest
2009
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Regulation of iron pathways in response to hypoxia
2010
Regulation of erythropoietin production
2010
Hypoxia and Inflammation
2011 Standout
Flexible polymer transistors with high pressure sensitivity for application in electronic skin and health monitoring
2013 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Relationship between oxidative stress and HIF-1α mRNA during sustained hypoxia in humans
2008
The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
2008
Physiological aspects of high-altitude pulmonary edema
2005
Erythropoietin Over-Expression Protects against Diet-Induced Obesity in Mice through Increased Fat Oxidation in Muscles
2009
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
Update in the Understanding of Respiratory Limitations to Exercise Performance in Fit, Active Adults
2008
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
The role of iron and reactive oxygen species in cell death
2013 Standout
Arterial blood pressure measurement and pulse wave analysis-–their role in enhancing cardiovascular assessment
2009
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Endurance Training and V˙O2max
2015
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
2009
Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
2012 Standout
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Prolonged Exposure to Hypobaric Hypoxia on Oxidative Stress, Inflammation and Gluco-Insular Regulation: The Not-So-Sweet Price for Good Regulation
2014
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension
2013
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
2012 Standout
Arterial Hypertension Induced by Erythropoietin and Erythropoiesis-Stimulating Agents (ESA)
2009
Combining Hypoxic Methods for Peak Performance
2009
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
2016 Standout
Revised Estimates for the Number of Human and Bacteria Cells in the Body
2016 Standout
Environmentally induced oxidative stress in aquatic animals
2010 Standout
ROS Are Good
2016 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Differential regulation of iron homeostasis during human macrophage polarized activation
2009
Pulmonary Artery Pressure in Lymphangioleiomyomatosis
2007
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
The human side of hypoxia‐inducible factor
2008 StandoutNobel
Erythropoiesis‐stimulating agents and other methods to enhance oxygen transport
2008
Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells
2005
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Iron Regulatory Proteins: From Molecular Mechanisms to Drug Development
2010
Epigenetic changes by DNA methylation in chronic and intermittent hypoxia
2017 StandoutNobel
Training intensity modulates changes in PGC‐1α and p53 protein content and mitochondrial respiration, but not markers of mitochondrial content in human skeletal muscle
2015
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Basic anatomical and physiological data for use in radiological protection: reference values
2002 Standout
Can we optimise the exercise training prescription to maximise improvements in mitochondria function and content?
2013
Pulmonary Arterial Hypertension
2006
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Hypoxic Pulmonary Vasoconstriction
2012
Mitochondria express enhanced quality as well as quantity in association with aerobic fitness across recreationally active individuals up to elite athletes
2012
Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring
2017 Standout
Improvements in exercise performance with high-intensity interval training coincide with an increase in skeletal muscle mitochondrial content and function
2013
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Physiological adaptations to interval training and the role of exercise intensity
2016 Standout
Acute and chronic effects of exercise on markers of mucosal immunity
2009
Basic anatomical and physiological data for use in radiological protection : reference values
2002
Iron-Deficiency Anemia
2015 Standout
Regulation of Hepcidin by Erythropoiesis: The Story So Far
2016
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity
2012
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease
2014
Macrophage plasticity and polarization in tissue repair and remodelling
2012 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Antioxidant supplementation does not attenuate oxidative stress at high altitude.
2004
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Works of Paul Robach being referenced
Operation Everest III (COMEX '97). Effects of prolonged and progressive hypoxia on humans during a simulated ascent to 8,848 M in a hypobaric chamber.
1999
Changes in cerebral blood flow and vasoreactivity to CO2 measured by arterial spin labeling after 6days at 4350m
2013
Operation Everest III (Comex'97): the effect of simulated severe hypobaric hypoxia on lipid peroxidation and antioxidant defence systems in human blood at rest and after maximal exercise
2001
Interactions between exposure to hypoxia and the training-induced autonomic adaptations in a “live high–train low” session
2005
Operation Everest III: energy and water balance
2000
Eighteen days of “living high, training low” stimulate erythropoiesis and enhance aerobic performance in elite middle-distance runners
2005
Living high–training low altitude training: effects on mucosal immunity
2005
Living high-training low: tolerance and acclimatization in elite endurance athletes
2005
Oxidative stress and HIF-1α modulate hypoxic ventilatory responses after hypoxic training on athletes
2009
Leukocyte's Hif-1 Expression and Training-Induced Erythropoietic Response in Swimmers
2006
Hypoxic Training
2014
The response of human skeletal muscle tissue to hypoxia
2009
Living high–training low: effect on erythropoiesis and maximal aerobic performance in elite Nordic skiers
2006
Comparative Response of EPO and Soluble Transferrin Receptor at High Altitude
2004
Mitochondrial function in human skeletal muscle following high‐altitude exposure
2012
Influence of “living high–training low” on aerobic performance and economy of work in elite athletes
2006
Effects of ATP-induced leg vasodilation on Vo 2 peakand leg O2extraction during maximal exercise in humans
2006
Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume
2006
Is it more effective for highly trained swimmers to live and train at 1200 m than at 1850 m in terms of performance and haematological benefits?
2006
Living high–training low: effect on erythropoiesis and aerobic performance in highly-trained swimmers
2005
Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension
2004
“Live high–train low” using normobaric hypoxia: a double-blinded, placebo-controlled study
2011
Serum hepcidin levels and muscle iron proteins in humans injected with low‐ or high‐dose erythropoietin
2013
Phlebotomy eliminates the maximal cardiac output response to six weeks of exercise training
2014
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin
2009
Determinants of time trial performance and maximal incremental exercise in highly trained endurance athletes
2011
Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle
2007
The role of haemoglobin mass on VO2max following normobaric ‘live high–train low’ in endurance-trained athletes
2012